Age, extra-pulmonary TB, low CD4 counts (<200 cells per cubic millimeter) at the time of initiating anti-TB treatment (ATT), and history of previous TB treatment have been independently associated with unfavourable treatment outcomes [5,8]. The gene discussed is CD4; the disease is tuberculosis.